Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner® Embolic Protection Catheter Designed to Protect Patients from Embolic Injury During ...

Emboline, Inc., a leading innovator in full-body embolic protection devices for transcatheter procedures, today announced completion of patient enrollment in its Protect the Head to Head (ProtectH2H) ...
Medscape

Study: Possible Cancerous Finding on Pre-TAVR CT Does Not Diminish Survival

ORLANDO, FL — In an observational study of nearly 100 elderly patients with severe aortic stenosis who had CT scans to see whether they were suitable candidates for transcatheter aortic-valve ...

Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results

Edwards Lifesciences Corporation (NYSE:EW) ranks among the best medical device stocks to invest in. Piper Sandler maintained ...
Nasdaq

Edwards Lifesciences Says FDA Approved TAVR Therapy For Asymptomatic Severe Aortic Stenosis

(RTTNews) - Edwards Lifesciences Corp. (EW) Thursday said that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform ...
Medical Dialogues

Antiplatelet therapy type Has Minimal Impact on Outcomes After Valve-in-Valve TAVR: Study

Researchers have found in a new study that among patients undergoing valve-in-valve transcatheter aortic procedures, ...
Medscape

Delirium Less Likely After TAVR Than Surgical Valve Replacement

Delirium is more common in patients undergoing surgical rather than transcatheter aortic valve replacement (SAVR, TAVR) but predicted worse in-hospital outcomes after both procedures, a new study ...
Seeking Alpha

MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting

ATLANTA, July 2, 2025 /PRNewswire/ -- The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, Piedmont Heart Institute, Atlanta and ...
Healio

Routine cerebral embolic protection shows no benefit for patients undergoing TAVR

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...
TCTMD

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

US hospitals pulled back on their use of cerebral embolic protection during TAVI after publication of the PROTECTED TAVR results, a new analysis affirms. The proportion of procedures done with the ...
News Medical

Heart failure patients benefit from dapagliflozin after TAVR procedure

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
News Medical

Embolic protection device does not reduce stroke rate in TAVR procedure

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Medindia

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China , Oct.